Literature DB >> 8417133

Delimitation of the proliferative stages in the human thymus indicates that cell expansion occurs before the expression of CD3 (T cell receptor).

L Alvarez-Vallina1, A González, F Gambón, M Kreisler, F Díaz-Espada.   

Abstract

Precursor of T lymphocytes undergo proliferation and maturation under the influence of the thymic microenvironment. In our study, we have attempted to determine the distribution of human postnatal thymocytes in division according to their stage of differentiation. Our data show that about 11.5% of all thymic cells are in S/G2/M phases, and that a subset of the cortical and precortical subpopulations contains most of the dividing cells. Rate of cell division is maintained at high levels from the prethymocyte precursor along the successive stages of differentiation represented by CD1+CD3-CD4-CD8- and CD1+CD3-CD4+CD8- cells. The percentage of dividing cells is maximal in an intermediate subset of CD1+CD3-CD4+CD8-CD45RO+ cells defined by the distinct expression of class I HLAdim/high molecules, which could contain cells in transit from prethymocytes to double-positive cortical cells. The CD3- fraction of the double-positive cortical cells contains most of the dividing thymocytes, although the rate of division within this subset is much less than that of the precursor CD1+CD3-CD4+CD8- cells. In a linear scheme of differentiation, cell division stops at or near the point of initiation of CD3 expression. These results suggest that in human thymus cell expansion takes place before the initiation of the positive selection process. According to this view the stringency of the selection process would require the previous generation of a large number of precursors to permit the production of sufficient numbers of mature T cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417133

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes.

Authors:  N L Perillo; C H Uittenbogaart; J T Nguyen; L G Baum
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

2.  Impaired expression of MHC class II molecules in response to interferon-gamma (IFN-gamma) on human thymoma neoplastic epithelial cells.

Authors:  M Inoue; M Okumura; S Miyoshi; H Shiono; K Fukuhara; Y Kadota; R Shirakura; H Matsuda
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

3.  Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor.

Authors:  N Sharfe; H K Dadi; M Shahar; C M Roifman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

4.  CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus.

Authors:  S G Kitchen; J A Zack
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

Review 5.  Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis.

Authors:  Meinoshin Okumura; Yoshitaka Fujii; Hiroyuki Shiono; Masayoshi Inoue; Masato Minami; Tomoki Utsumi; Yoshihisa Kadota; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-04-10

6.  Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro.

Authors:  H Valentin; M T Nugeyre; F Vuillier; L Boumsell; M Schmid; F Barré-Sinoussi; R A Pereira
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

7.  CD81 expressed on human thymocytes mediates integrin activation and interleukin 2-dependent proliferation.

Authors:  S C Todd; S G Lipps; L Crisa; D R Salomon; C D Tsoukas
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

8.  Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors.

Authors:  Lauren J Howson; Katrina M Morris; Takumi Kobayashi; Cesar Tovar; Alexandre Kreiss; Anthony T Papenfuss; Lynn Corcoran; Katherine Belov; Gregory M Woods
Journal:  Anat Rec (Hoboken)       Date:  2014-03-24       Impact factor: 2.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.